Business
Currency:USD
2023/FY
Stock NameRevenueRatio
Nucleic acid production224.77M77.79%
Biologics safety testing64.18M22.21%
Intersegment eliminations-3K0.00%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
North America141.06M48.82%
Asia Pacific97.44M33.72%
Europe, the Middle East and Africa49.92M17.28%
Latin and Central America527K0.18%